Trevena, Inc. to Present at September Virtual Investor Conferences

Sep 02, 2020 7:00am EDT

Trevena Announces Publications of OLINVYK™ Respiratory Safety Analyses vs. IV Morphine

Aug 26, 2020 7:00am EDT

Trevena Announces Initiation of TRV027 Study in COVID-19 Patients in Collaboration With Imperial College London

Aug 24, 2020 7:00am EDT

Trevena Announces Receipt of Milestone Payment Under Partnership in China With Jiangsu Nhwa Pharmaceutical Co.

Aug 20, 2020 7:36am EDT

Trevena to Present at the Virtual JMP Securities CNS Forum

Aug 14, 2020 1:42pm EDT

Trevena Announces Pricing of $50 Million Public Offering of Common Stock

Aug 12, 2020 9:27am EDT

Trevena Announces Proposed Public Offering of Common Stock

Aug 11, 2020 4:01pm EDT

Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection

Aug 10, 2020 6:30am EDT

Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.

Jun 03, 2020 8:02am EDT

Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients

Jun 02, 2020 7:00am EDT